European Patent Bulletin 2012/36 - European Patent Office
09.02.2013 • Views
Share Embed Flag

European Patent Bulletin 2012/36 - European Patent Office

European Patent Bulletin 2012/36 - European Patent Office

European Patent Bulletin 2012/36 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

(A61K) II.1(1)<br />

IMMUNOMODUATING AGENT, ANTI-<br />

CANCER AGENT AND HEALTH FOOD<br />

CONTAINING MONOACETYLDIACYL-<br />

GLYCEROL DERIVATIVES<br />

AGENT IMMUNOMODULATEUR, AGENT<br />

ANTICANCEREUX, ET ALIMENT DIETE-<br />

TIQUE CONTENANT DES DERIVES DE<br />

MONOACETYL-DIACYLGLYCEROL<br />

(73) Enzychem Lifesciences Corporation, Kaist-<br />

ICC F741, 193, Munji-Ro Yusung-gu,<br />

Daejeon 305-701, KR<br />

(72) Kim, Sang Hee, Seol 138-169, KR<br />

(74) Merkle, Gebhard, TER MEER STEINMEISTER<br />

& PARTNER GbR, <strong>Patent</strong>anwälte Mauerkircherstrasse<br />

45, 81679 München, DE<br />

A61K 31/225 → (51) C07C 229/00<br />

A61K 31/235 → (51) C07C 311/18<br />

A61K 31/341 → (51) C07C 237/<strong>36</strong><br />

A61K 31/345 → (51) C07D 213/40<br />

(51) A61K 31/353 (11) 1 976 507 B1<br />

A61K 31/357 A61P 25/08<br />

(25) En (26) En<br />

(21) 06847861.9 (22) 19.12.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(43) 08.10.2008<br />

(86) US 2006/048682 19.12.2006<br />

(87) WO 2007/075834 2007/27 05.07.2007<br />

(30) 19.12.2005 US 751496 P<br />

18.12.2006 US 612174<br />

(54) VERWENDUNG VON BENZOKONDEN-<br />

SIERTEN HETEROCYCLISCHEN SULFA-<br />

MID-DERIVATEN ZUR BEHANDLUNG VON<br />

EPILEPTOGENESE<br />

USE OF BENZO-FUSED HETEROCYCLE<br />

SULFAMIDE DERIVATIVES FOR THE<br />

TREATMENT OF EPILEPTOGENESIS<br />

UTILISATION DE DERIVES DE SULFA-<br />

MIDE HETEROCYCLIQUE BENZO-<br />

FUSIONNE POUR TRAITER L'ÉPILEPTGE-<br />

NÈSE<br />

(73) Janssen Pharmaceutica N.V., Turnhoutseweg<br />

30, 2340 Beerse, BE<br />

(72) SMITH-SWINTOSKY, Virginia L., Hatfield,<br />

Pennsylvania 19440, US<br />

(74) Warner, James Alexander, et al, Carpmaels &<br />

Ransford One Southampton Row, London<br />

WC1B 5HA, GB<br />

A61K 31/357 → (51) A61K 31/353<br />

A61K 31/<strong>36</strong> → (51) C07C 237/<strong>36</strong><br />

A61K 31/381 → (51) C07C 237/<strong>36</strong><br />

A61K 31/381 → (51) C07C 311/18<br />

A61K 31/401 → (51) C07K 5/06<br />

A61K 31/403 → (51) A01N 1/02<br />

A61K 31/403 → (51) C07D 209/94<br />

A61K 31/4152 → (51) A61K 9/22<br />

A61K 31/4164 → (51) A61K 9/08<br />

A61K 31/422 → (51) C07D 413/12<br />

A61K 31/435 → (51) C07D 209/94<br />

A61K 31/435 → (51) C07D 213/56<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

A61K 31/435 → (51) C07D 401/14<br />

A61K 31/435 → (51) C07D 471/04<br />

A61K 31/435 → (51) C07K 5/06<br />

A61K 31/4353 → (51) C07D 211/46<br />

A61K 31/4<strong>36</strong>5 → (51) A61K 9/16<br />

A61K 31/4<strong>36</strong>5 → (51) C07D 209/94<br />

A61K 31/437 → (51) C07D 471/04<br />

A61K 31/438 → (51) C07D 495/20<br />

A61K 31/439 → (51) C07D 471/18<br />

A61K 31/44 → (51) A01N 43/42<br />

A61K 31/44 → (51) C07C 311/18<br />

A61K 31/44 → (51) C07D 213/64<br />

A61K 31/44<strong>36</strong> → (51) C07C 311/18<br />

A61K 31/4439 → (51) A61K 9/14<br />

A61K 31/4525 → (51) C07D 405/12<br />

A61K 31/453 → (51) A01N 1/02<br />

A61K 31/47 → (51) C07D 215/14<br />

A61K 31/4709 → (51) C07D 215/14<br />

A61K 31/475 → (51) A61P 35/00<br />

A61K 31/495 → (51) A01N 1/02<br />

A61K 31/495 → (51) A61K 9/22<br />

A61K 31/495 → (51) C07D 213/56<br />

A61K 31/497 → (51) C07D 241/28<br />

A61K 31/498 → (51) A61K 9/08<br />

A61K 31/501 → (51) C07D 401/04<br />

A61K 31/505 → (51) C07D 487/04<br />

A61K 31/538 → (51) C07D 209/94<br />

A61K 31/538 → (51) C07D 413/04<br />

A61K 31/55 → (51) C07D 209/94<br />

A61K 31/557 → (51) A61K 9/08<br />

A61K 31/57 → (51) C07J 41/00<br />

A61K 31/575 → (51) A23L 1/30<br />

A61K 31/58 → (51) C07J 41/00<br />

A61K 31/592 → (51) A61K 33/24<br />

A61K 31/593 → (51) A61K 33/24<br />

A61K 31/662 → (51) A61K 9/22<br />

A61K 31/7016 → (51) C13K 3/00<br />

A61K 31/7048 → (51) A61K 9/22<br />

A61K 31/716 → (51) A23L 1/30<br />

A61K 33/00 → (51) A61K 9/14<br />

587<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>36</strong>/<strong>2012</strong>) 05.09.<strong>2012</strong><br />

(51) A61K 33/24 (11) 2 266 584 B1<br />

A61K 31/592 A61K 31/593<br />

A61P 19/08<br />

(25) En (26) En<br />

(21) 10185878.5 (22) 06.05.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PL PT RO SE SI<br />

SK TR<br />

(43) 29.12.2010<br />

(30) 07.05.2003 DK 200300691<br />

20.06.2003 DK 200300931<br />

09.12.2003 DK 200301819<br />

09.12.2003 US 528548 P<br />

(54) Strontium-Vitamin D-Zusammensetzung<br />

zur Prophylaxe/Behandlung von Knorpelund<br />

Knochenzuständen<br />

Composition with strontium and vitamin D<br />

for the prophylaxis and/or treatment of<br />

cartilage and/or bone conditions<br />

Composition contenant du strontium et de<br />

la vitamine D pour la prophylaxie et/ou le<br />

traitement de pathologies des cartilages<br />

et/ou des os<br />

(73) Osteologix A/S, Symbion Science Park,<br />

Fruebjergvej 3, 2100 Copenhagen, DK<br />

(72) Christgau, Stephan, DK-2820 Gentofte, DK<br />

Hansen, Christian, DK-2950 Vedbæk, DK<br />

Nilsson, Henrik, 8835 Feusisberg, CH<br />

(74) Bender, Mikkel, et al, Chas. Hude A/S H.C.<br />

Andersens Boulevard 33, 1780 Copenhagen<br />

V, DK<br />

(62) 04731315.0 / 1 622 630<br />

(51) A61K 33/<strong>36</strong> (11) 2 209 480 B1<br />

A61P 35/00<br />

(25) En (26) En<br />

(21) 08848529.7 (22) 31.10.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

(43) 28.07.2010<br />

(86) US 2008/012385 31.10.2008<br />

(87) WO 2009/061373 2009/20 14.05.2009<br />

(30) 02.11.2007 US 1575<br />

(54) KOMBINATIONSTHERAPIE MIT ORGANI-<br />

SCHEN ARSENHALTIGEN STOFFEN<br />

COMBINATION THERAPY WITH ORGANIC<br />

ARSENICALS<br />

THÉRAPIE DE COMBINAISON AVEC DES<br />

COMPOSÉS ARSENICAUX ORGANIQUES<br />

(73) ZIOPHARM ONCOLOGY, INC., One First<br />

Avenue Parris Building No. 34 Navy Yard<br />

Plaza, Boston, MA 02129, US<br />

(72) WALLNER, Barbara, P., Cohasset MA 02025,<br />

US<br />

KOMARNITSKY, Philip, B., Chestnut Hill MA<br />

02467, US<br />

(74) Dehmel, Albrecht, Dehmel & Bettenhausen<br />

<strong>Patent</strong>anwälte Herzogspitalstrasse 11, 80331<br />

München, DE<br />

A61K 33/38 → (51) A61K 9/16<br />

A61K 35/76 → (51) A23K 1/17<br />

A61K <strong>36</strong>/00 → (51) A61K 9/14<br />

A61K <strong>36</strong>/00 → (51) A61K 31/015<br />

A61K <strong>36</strong>/24 → (51) A61P 35/00<br />

(51) A61K <strong>36</strong>/58 (11) 1 819 352 B1<br />

A61K 9/00<br />

(25) En (26) En<br />

(21) 05764528.5 (22) 21.07.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT<br />

RO SE SI SK TR<br />

(43) 22.08.2007<br />

(86) BR 2005/000132 21.07.2005

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!